Aeterna Zentaris to Present at Upcoming Canaccord Genuity Global Growth Conference in Boston

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\nQUÉBEC CITY, Aug. 7, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that the Company's\n Senior Vice President and CFO, Dennis Turpin, CPA, CA, will be\n presenting a corporate overview at the Canaccord Genuity 33rd Annual Global Growth Conference on Wednesday, August 14, 2013, at 11:00\n am (Eastern), in the Paris Room of the Intercontinental Boston Hotel.\n\n\nA live audio webcast of this presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com in the Newsroom section. A replay of the webcast will also be available\n on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in\n developing novel treatments in oncology and endocrinology. The\n Company's pipeline encompasses compounds from drug discovery to\n regulatory approval. For more information, visit www.aezsinc.com.\n\nSOURCE: Aeterna Zentaris Inc.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected]  Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] Copyright CNW Group 2013","length":2043,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.